- Home
- VRDN vs LC Comparison
VRDN vs LC Comparison
Compare VRDN & LC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- LC
- Stock Information
- Founded
- VRDN 2006
- LC 2006
- Country
- VRDN United States
- LC United States
- Employees
- VRDN N/A
- LC N/A
- Industry
- VRDN Medical Specialities
- LC Finance: Consumer Services
- Sector
- VRDN Health Care
- LC Finance
- Exchange
- VRDN Nasdaq
- LC Nasdaq
- Market Cap
- VRDN 1.0B
- LC 1.0B
- IPO Year
- VRDN N/A
- LC 2014
- Fundamental
- Price
- VRDN $14.04
- LC $10.06
- Analyst Decision
- VRDN Strong Buy
- LC Strong Buy
- Analyst Count
- VRDN 12
- LC 8
- Target Price
- VRDN $38.50
- LC $15.75
- AVG Volume (30 Days)
- VRDN 838.2K
- LC 1.2M
- Earning Date
- VRDN 05-06-2025
- LC 04-29-2025
- Dividend Yield
- VRDN N/A
- LC N/A
- EPS Growth
- VRDN N/A
- LC 28.90
- EPS
- VRDN N/A
- LC 0.44
- Revenue
- VRDN $302,000.00
- LC $1,195,590,000.00
- Revenue This Year
- VRDN N/A
- LC N/A
- Revenue Next Year
- VRDN $21,976.14
- LC $19.11
- P/E Ratio
- VRDN N/A
- LC $22.81
- Revenue Growth
- VRDN 4.86
- LC 8.77
- 52 Week Low
- VRDN $9.90
- LC $7.81
- 52 Week High
- VRDN $27.20
- LC $18.75
- Technical
- Relative Strength Index (RSI)
- VRDN 55.33
- LC 43.15
- Support Level
- VRDN $13.37
- LC $9.84
- Resistance Level
- VRDN $14.18
- LC $10.28
- Average True Range (ATR)
- VRDN 0.67
- LC 0.31
- MACD
- VRDN 0.12
- LC -0.06
- Stochastic Oscillator
- VRDN 71.43
- LC 7.98
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About LC LendingClub Corporation
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.